
Commentary|Videos|August 4, 2025
Molecular Testing in Lung Cancer: Personalized Diagnostics Are Transforming Care
Author(s)Luis E Raez, MD, FASCO, FACP
Luis E. Raez, MD, FACP, FASCO, dives into evolving practices in molecular testing for patients with lung cancer.
Advertisement
Luis E. Raez, MD, FACP, FASCO, dives into the evolving use of molecular testing for patients with lung cancer. Raez is the medical director of Memorial Cancer Institute, oncology research director of Memorial Health Care System, and director of the Thoracic Oncology Program at the Florida Society of Clinical Oncology. He is also a clinical associate professor of medicine at Florida International University and a visiting professor of medicine at Cayetano Heredia University in Peru.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5



































